Syndax Pharmaceuticals Garners $4,947,480 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=256cec88-6fcc-4003-9b87-4ee6b3fe2e8e
Date
9/22/2014
Company Name
Syndax Pharmaceuticals
Mailing Address
400 Totten Pond Road Waltham, MA 02451 USA
Company Description
Syndax Pharmaceuticals, Inc. is a Waltham, MA-based, oncology-focused biotechnology company that is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens.
Website
http://www.syndax.com
Transaction Type
Debt
Transaction Amount
$4,947,480
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor